mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |